Background Cardiac amyloidosis is a fatal disease whose prognosis and treatment rely on
identification of the amyloid type. In our aging population transthyretin amyloidosis ( ATTR wt) …

Purpose Chemotherapy in AL (primary or light chain) amyloidosis is associated with
improved survival, but its effect on renal outcome has not been examined systematically. The …

Rationale: Baseline circulating concentrations of C-reactive protein (CRP) are significantly
associated with cardiovascular disease risk in general populations. This modest association …

Background 25-hydroxyvitamin D deficiency is associated with COPD and increased
susceptibility to infection in the general population. Methods We investigated whether COPD …

Objectives To explore the long‐term clinical outcomes following intravascular lithotripsy (IVL)
in calcified coronary lesions from a real‐world population. Background IVL is a relatively …

Primary light chain (AL) amyloidosis, the commonest type of amyloidosis, presents with cardiac
involvement in 50% of patients. Cardiac amyloidosis causes a restrictive cardiomyopathy …

Intracoronary guidewires used in percutaneous coronary intervention can also be configured
to provide temporary ventricular pacing. Trans coronary electrophysiological parameters …

Objective To assess the incidence of thyroid dysfunction (TD) in a UK cohort of patients with
hepatitis C virus (HCV) infection treated with interferon‐α (IFNα) and ribavirin combination …

Introduction Percutaneous coronary intervention is performed routinely in the management
of myocardial infarction with obstructive coronary disease, but intervention to arteries …

Very short duration of dual antiplatelet therapy (DAPT) following percutaneous coronary
intervention (PCI) has recently attracted a lot of attention with the introduction of newer …